A growing library of the omega-3 research we're following — summarized and categorized so you can find what matters to you.
In diabetic patients, omega-3 supplementation was linked to lower triglycerides and reduced Apo AII levels compared to controls.
This review found that omega-3 fatty acids are consistently linked to improvements in liver fat, triglycerides, and some liver enzymes in MAFLD research, while newer bioactive fats like furan fatty acids and FAHFAs show early but inconsistent findings.
Across 58 studies, at least 1,000-1,500 mg/day of EPA plus DHA as triglycerides for 12+ weeks was the lowest dose consistently shown to raise the omega-3 index to recommended levels.
This review summarizes evidence that omega-3 fatty acids help balance inflammation and immune activity, with links to better outcomes in autoimmune, viral, and age-related conditions across prior studies.
This review summarizes how omega-3 fatty acids may help regulate inflammation involved in obesity, metabolic disorders, and several chronic inflammatory conditions.
A lab-engineered nanofiber patch successfully delivered oxidation-prone omega-3 oils (DHA/EPA) to skin cells in vitro, releasing them steadily over 120 hours with good cell tolerability.
High-dose krill oil supplementation for 12 weeks was linked to reduced arterial stiffness and changes in platelet aggregation compared to placebo in healthy adults.
A newly launched Brazilian trial will test whether adding phytosterols and/or krill oil to a heart-healthy diet improves cholesterol markers in people with familial hypercholesterolaemia, with results expected by mid-2026.
In well-nourished men doing resistance training, high-dose omega-3 supplementation was well absorbed into muscle but did not improve muscle growth, strength, or anabolic signaling compared to placebo.